RESOURCES

/

FIND A SPECIALIST

/

CONTACT

A First for FSGS Patients: What the sparsentan Approval Means for You

Headline decoration line

Click to Watch…

During this live discussion, moderated by NephCure’s COO Lauren Eva and CEO Josh Tarnoff, leading physicians Drs. Kirk Campbell, Laura Mariani, and Howard Trachtman walked through what this sparsentan FDA approval means for the FSGS community. They also discussed who may benefit and what patients and families should know as they navigate next steps.

Visit our Youtube page

Support

Get help coping with the challenges of living with FSGS through support groups like NephCure. Learn more about our how we can support you.

Nutrition

Eat a diet low in salt and processed foods to manage your blood pressure and reduce strain on your kidneys. Learn more about a kidney-friendly diet and get our cookbook.

Latest Resources

Nephcure Site Image
Informational Documents

Sparsentan (FILSPARI) for FSGS: FAQs

Fact Sheet

Congenital Nephrotic Syndrome & Infantile Nephrotic Syndrome

Video

A First for FSGS Patients: What the sparsentan Approval Means for You

Educational Materials

School Accomodations

ALL RESOURCES

Sign up to get NephCure’s latest updates.

SIGN UP
This field is for validation purposes and should be left unchanged.